Latest pharma updates on IgA Nephropathy (IgAN)

FDA Approves Otsuka’s Voyxact for IgA Nephropathy (IgAN)

Otsuka's monoclonal antibody Voyxact has received FDA approval for the treatment of primary IgA nephropathy (IgAN) i...

Read Full Story
PharmaTradZ Logo

Advertise on PharmaTradZ

Reach verified pharma buyers, suppliers & decision makers worldwide.

Discover Opportunities
PharmaTradZ Logo

Explore Pharma Investment Opportunities

Connect with partners, startups & ventures driving the future of pharma.

Discover Opportunities
PharmaTradZ Logo

Grow Your Pharma Brand

Advertise on the fastest-growing B2B pharma marketplace.

Start Advertising

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
Join WhatsApp Group for Latest Updates
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.